QRONS INC.
MIAMI BEACH, FLORIDA

About Qrons Founded in 2016, Qrons is a publicly traded, preclinical biotechnology company, developing advanced cell-based solutions to combat neurological injuries. While we are laser-focused on traumatic brain injury (TBI), our technology could potentially treat a wide range of neurodegenerative diseases. TBI presents many complex challenges. To overcome these, Qrons has developed a coordinated group of product-oriented research teams. Qrons’ co-founders, Jonah Meer and Ido Merfeld, believe it’s time to upend the traditional approach to developing new treatments. The two have a long history of bringing disruptive ideas into well-established sectors. Their collaborative mindset fuels Qrons’ efforts to solve TBI and other neuronal conditions. By combining stellar scientists with innovative business people, Qrons is redesigning how scientific teams come together to find solutions. This unique approach seeks to create the best possible treatments in the least possible time. We are developing 3D printable smart material scaffolds, innovative mesenchymal stem cell lines and a novel delivery system to repair and regenerate neuronal damage. See what’s been going on behind the scenes at Qrons by reading the latest information on our company. We invite you to visit often, as updates are made regularly. p: 786.620.2140 | qrons.com e: [email protected]